Delivery Order SPE2DB22D2211-SPE2DB25FSBGE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,466.85 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjectors. This firm fixed-price, competitively awarded contract was executed on May 27, 2025, with an ultimate completion date of May 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/mL auto-injectors, a specialty pharmaceutical product, with a ceiling value of $26,727.10. This firm fixed-price delivery order, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,783.88 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The contract represents a single shipment of this specialty...
- The Defense Logistics Agency awarded a $45,373.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with a completion date of July 22, 2025. This non-set-aside contract represents a direct procurement of a specialized pharmaceutical product to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a $69,112.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with an ultimate completion date of August 5, 2025. This competitive award, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $84,390.90 delivery order to AmerisourceBergen Drug Corp on May 7, 2025, for the supply of Bimzelx 160 mg/mL auto-injector medication. This firm fixed-price delivery order, with an ultimate completion date of May 8, 2025, was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $35K to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector pharmaceutical products. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken....
- The Defense Logistics Agency awarded a delivery order valued at $77,678.05 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injector units, with performance completion targeted for September 10, 2025. The award was competitively procured without set-aside designation under a firm fixed-price delivery order structure. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,057.06 to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a $11,394.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injector product, with an ultimate completion date of August 6, 2025. This competitively awarded contract, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBGEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,170.09 to AmerisourceBergen Drug Corp for BIMZELX 160 MG/ML AutoInjector on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award involved no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which enables the company to deliver a broad range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. BIMZELX is a specialty pharmaceutical product delivered via auto-injector format, consistent with AmerisourceBergen's portfolio of specialized medical supplies and injectable medications. The company's demonstrated capability in fulfilling diverse federal medical supply requirements across delivery values ranging from minimal to substantial transactions positions it as a key provider within the Defense Logistics Agency's pharmaceutical supply chain supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 7/21/25 |